Detalhe da pesquisa
1.
Interleukin-37 promotes DMBA/TPA skin cancer through SIGIRR-mediated inhibition of glycolysis in CD103+DC cells.
MedComm (2020)
; 4(2): e229, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36891351
2.
Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction.
Signal Transduct Target Ther
; 7(1): 19, 2022 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35046386